Back

Relief of dyspnoea after TAVI is associated with improvement in left ventricular systolic function

28 August 2026 (12:15 - 13:00)
Organised by: Logo
Congress Presentation Part of: Structural heart disease: outcomes, heart failure, myocardial function, and reintervention Aortic Valve Intervention ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speakers

Photo
Doctor Constantijn Sebastiaan Venema

University Medical Centre Groningen, Groningen (Netherlands (The))

Photo
Mr Kyriakos Panaou

(Netherlands (The))

7 More presentations in this session

Presentation thumbnail
Surgical bioprosthesis true ID and fracture impact on gradients after valve-in-valve TAVI
Doctor G. Papadopoulos (Thessaloniki, GR)
Abstract Slides
Presentation thumbnail
Long-term changes in pacemaker stimulation burden and its influence on clinical outcomes after transcatheter aortic valve implantation: a multicenter study
Doctor R. Schmitt (Bad Krozingen, DE)
Abstract Slides
Presentation thumbnail
The current state of TAVI in Germany – a nationwide assessment
Doctor D. Grundmann (Hamburg, DE)
Abstract Slides
Presentation thumbnail
Construct validity of a fibre-optic pressure sensor integrated TAVI guidewire for invasive pressure measurements in transcatheter aortic valve implantation: a prospective registry
Mr G. Versteeg (Nijmegen, NL)
Abstract Slides
Presentation thumbnail
Transcatheter tricuspid valve repair: long-term survival and economic implications in a German real-world cohort
Doctor K. Piayda (Giessen, DE)
Abstract Slides

Access the full session

Session thumbnail
Structural heart disease: outcomes, heart failure, myocardial function, and reintervention

The Event

Event poster

ESC Congress 2026

28 August 2026 12:15 CET
You may be interested in
thumbnail
Congress Presentation
Left ventricular deformation in patients undergoing TAVI
29 June 2021
thumbnail
Congress Presentation
In patients with unexplained dyspnea and preserved left ventricular ejection fraction CPETecho is a useful tool to establish the cause of dyspnea
21 May 2023
thumbnail
Congress Presentation
Sacubitril/valsartan is associated with improved pulmonary haemodynamics in patients with heart failure with reduced ejection fraction
29 June 2021
thumbnail
Congress Presentation
Discordance between symptomatic response and changes in cardiac structure and function one year after transcatheter aortic valve implantation
30 August 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources